Magnetic resonance imaging (MRI) and ultrasound (US) showed comparable agreement with post-therapy pathological tumour size.
•
MRI estimated residual tumour size with <10-mm discordance in 54% of patients.
•
US estimated residual tumour size with <10-mm discordance in 63% of patients.
•
US has the advantage of lower cost and wider availability compared to MRI.
•
Imaging post-therapy showed a low negative predictive value in hormone receptor-positive tumours.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.